NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

417 hedge funds and large institutions have $8.63B invested in Neurocrine Biosciences in 2020 Q3 according to their latest regulatory filings, with 70 funds opening new positions, 188 increasing their positions, 109 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
417
Holders Change
–
Holders Change %
0%
% of All Funds
8.44%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.14%
New
70
Increased
188
Reduced
109
Closed
68
Calls
$40.5M
Puts
$136M
Net Calls
-$95.1M
Net Calls Change
-$101M

Top Buyers

1
CAM
1
Congress Asset Management
Massachusetts
$73.8M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$207M
3
HM
3
HealthCor Management
New York
$89.1M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$837M
5
Fiera Capital (Canada)
5
Fiera Capital (Canada)
Quebec, Canada
$27.5M

Top Sellers

1
Capital International Investors
1
Capital International Investors
California
$411M
2
BlackRock
2
BlackRock
New York
$655M
3
PA
3
Perceptive Advisors
New York
$149M
4
Jennison Associates
4
Jennison Associates
New York
$0
5
Deutsche Bank
5
Deutsche Bank
Germany
$48.9M
Name Holding Trade Value Shares
Change 		Shares
Change %
CFA
476
Carroll Financial Associates
North Carolina
– -$2K -18 Closed
TI
477
tru Independence
Oregon
– -$2 -18 Closed
WAM
478
Wolverine Asset Management
Illinois
– -$1K -15 Closed
HFM
479
Hartford Financial Management
Connecticut
– -$1K -10 Closed
BL
480
Balentine LLC
Georgia
– -$1K -9 Closed
MPWT
481
MassMutual Private Wealth & Trust
Connecticut
– -$1K -6 Closed
16 17 18 19
20